Cholangiocarcinoma and gallbladder cancer

Prof Gruenberger talks with ecancer at ESMO GI 2017 about the diagnosis and treatment of cholangiocarcinoma dependant on the variables of the disease. He goes onto discuss the surgical options for different entities of cholangiocarcinoma. He then continues to review a recent phase III trial that found that giving adjuvant capecitabine was beneficial in terms of overall survival for patients.

• Kategori